Control infants with thrombocytopenia and with high CRP had the highest rate of severe ROP, 100% (8/8), while AA/DHA supplemented infants without thrombocytopenia and without high CRP had the lowest rate, 15.9% (10/63). The gene discussed is CRP; the disease is retinopathy of prematurity.